Try our Advanced Search for more refined results
June 26, 2020
Zachary Silbersher, et al v. Dr. Falk Pharma GmbH, et al
Case Number:
20-16256
Court:
Nature of Suit:
Companies
- Adamas Pharmaceuticals Inc.
- Bausch Health Cos. Inc.
- BTG International Inc.
- BTG PLC
- Johnson & Johnson
- Salix Pharmaceuticals, Ltd.
- Taxpayers Against Fraud Education Fund
Government Agencies
- Commonwealth of Massachusetts
- State of Indiana
- State of Maryland
- State of Michigan
- State of Nevada
- State of Tennessee
- U.S. District Court for the District of Columbia
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
June 10, 2022
9th Circ. Mulls If Valid Patents Moot FCA Suit Against Bausch
A Ninth Circuit judge considering whistleblower allegations that Bausch Health fraudulently obtained a patent to prolong its monopoly on colitis drug Apriso pressed the plaintiff's attorney Friday on whether other valid patents also protected the drug, commenting, "If that's the case, then you don't have a False Claims Act claim."
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login